Company News

AVITA Medical (ASX:AV) secures FDA approval

30 Dec 2019 - AVITA Medical (ASX:AVH, NASDAQ:RECEL) has announced the resignation of joint company secretary Tamara Barr and secured US FDA approval to conduct a feasibility study evaluating the safety and effectiveness of the RECELL® Autologous Cell Harvesting Device for repigmentation of lesions.

Read more...